In the BioHarmony Drug Report Database
Dirithromycin
Dynabac (dirithromycin) is a small molecule pharmaceutical. Dirithromycin was first approved as Dynabac on 1995-06-19. It is used to treat bacterial pneumonia, bronchitis, community-acquired infections, haemophilus infections, and staphylococcal infections amongst others in the USA.
Trade Name
|
Dynabac |
|---|---|
Common Name
|
dirithromycin |
ChEMBL ID
|
CHEMBL1237072 |
Indication
|
bacterial pneumonia, bronchitis, community-acquired infections, haemophilus infections, staphylococcal infections, streptococcal infections, tonsillitis |
Drug Class
|
Antibiotics (Streptomyces strains) |
Image (chem structure or protein)